New data presented today confirms that a novel first-in-class treatment for Hepatitis B, called NVR 3-778, is well-tolerated and can reduce levels of the virus' genetic material in the body when combined with pegylated interferon ...
Apr 16, 2016
0
15
(HealthDay)—For patients with stage 1 hypertension, low-dose chlorthalidone is associated with reduction in ambulatory blood pressure (ABP), while low-dose hydrochlorothiazide (HCTZ) may result in masked hypertension, according ...
Jan 28, 2016
0
0
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson's disease and Lewy body dementia in a small phase I clinical trial, report researchers at Georgetown University ...
Oct 18, 2015
0
240
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in ...
Aug 31, 2015
0
11
(Medical Xpress) -- Menopausal women with non-alcoholic fatty liver disease (NAFLD) who don’t consume enough of the essential nutrient choline appear to be at higher risk for liver scarring, according to research led ...
Feb 17, 2012
0
0
